
Opinion|Videos|January 29, 2025
Patient Selection Criteria for Different Versions of Abiraterone Acetate in mCRPC
Author(s)Jose De La Cerda III, MD, MPH
This video segment discusses patient selection criteria for choosing between the original brand, generic, and micronized versions of abiraterone.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Can you share your patient selection criteria for different versions of abiraterone?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Laura Bukavina, MD, and Gabriela Díaz, MD, on the rise of young-onset bladder cancer
3
Individualizing androgen pathway therapy in mCSPC
4
BOND-003 Cohort C: Efficacy Results
5







